iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Sun Pharmaceuticals Industries Ltd Option Chain

1,693.6
(-0.58%)
Jul 18, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,400₹0.15 -25%51,45079.26%
00%₹254.8 0%1,440₹0.25 -16.66%53,55014.17%
7000%₹200 0%1,480₹0.15 -25%2,22,9500%
7000%₹169.15 0%1,500₹0.35 -12.5%4,02,1500.61%
00%₹175.8 0%1,520₹0.4 0%18,2000%
5,6000%₹156.8 0%1,540₹0.8 0%1,50,1500.46%
4,9000%₹145.4 0%1,560₹0.9 12.5%72,450-6.33%
10,1500%₹134 0%1,580₹1.15 15%71,400-0.97%
55,30029.50%₹99 -11.6%1,600₹1.8 33.33%3,74,5000.65%
54,950-5.98%₹81.4 -7.65%1,620₹2.55 37.83%1,31,9500.26%
85,7508.40%₹62.4 -13.09%1,640₹4 42.85%2,62,500-1.57%
1,50,8507.21%₹46 -14.97%1,660₹6.8 37.37%3,26,200-11.32%
3,73,100-5.41%₹31 -18.52%1,680₹12.55 37.15%3,09,050-1.99%
22,34,750-0.35%₹18.7 -25.2%1,700₹20.25 28.16%5,08,900-24.74%
24,81,850-0.05%₹11 -30.37%1,720₹32 21.21%4,58,150-12.61%
14,80,850-0.30%₹7.1 -31.73%1,740₹46.9 13.42%1,15,150-21.29%
6,78,3000.10%₹4.25 -35.6%1,760₹66.15 16.25%32,550-30.07%
3,54,9004.21%₹2.8 -37.07%1,780₹68.35 0%15,0500%
7,19,9501.13%₹2.1 -34.37%1,800₹103.05 10.74%61,9500.56%
1,44,200-13.44%₹1.5 -30.23%1,820₹93.1 0%9,8000%
2,84,900-2.16%₹1 -28.57%1,840₹138.35 3.51%4,90040%
1,23,550-20.13%₹0.65 -31.57%1,860--
2,96,450-0.23%₹0.5 -9.09%1,880₹220 0%1,4000%
73,850-7.45%₹0.4 14.28%1,920₹193 0.12%3,5000%
3,85037.5%₹0.5 11.11%1,960--

Sun Pharma.Inds.: Related NEWS

Top Stocks for Today - 15th July 2025
15 Jul 2025|06:24 AM

Here are some of the stocks that may see significant price movement today: Power Mech Projects, Rail Vikas Nigam, Rallis India, etc.

Read More
Top Stocks for Today - 16th June 2025
16 Jun 2025|06:23 AM

Here are some of the stocks that may see significant price movement today: Sun Pharma, Vedanta, SpiceJet, etc.

Read More
US FDA Flags 8 Observations at Sun Pharma’s Halol Facility After GMP Inspection
15 Jun 2025|11:50 PM

The visit lasted from June 2 to June 13 and focused on checking for compliance with Good Manufacturing Practices.

Read More
Sun Pharma Expands Specialty Drug Pipeline with $25 Million Pharmazz Deal
24 May 2025|07:51 PM

Both treatments have already received approvals in India and are available for sale there with local partners under a brand known as Tyvalzi and Lyfaquin.

Read More
Sun Pharma Q4 FY25 Revenue Rises 8.5% to ₹12,816 Crore
23 May 2025|12:07 PM

The Board recommended a final dividend of ₹5.50 per share for FY25.

Read More
Top Stocks for Today - 7th May 2025
7 May 2025|08:06 AM

NLC's subsidiary has executed a PPA with Rajasthan Rajya Vidyut Utpadan Nigam Ltd. (RVUNL) for 810 MW solar power plant at Pugal Solar Park, Rajasthan

Read More
Sun Pharma’s MM-II Trial Shows Long-Lasting Relief for Knee Osteoarthritis
26 Apr 2025|01:15 PM

Based on the Phase 2b clinical trial, the study used a randomised, double-blind, placebo-controlled design that yielded strong and dependable data.

Read More
Sun Pharma to Acquire Nasdaq-Listed Checkpoint Therapeutics for $355 Million
10 Mar 2025|10:46 AM

The deal is expected to be completed in the second quarter of 2025, subject to customary closing conditions and regulatory approvals.

Read More
Sun Pharma Q3 Profit Jumps 19% YoY, Declares ₹10.50 Dividend
31 Jan 2025|10:17 PM

An interim dividend of ₹10.50 on the face value per share for FY25 has been declared.

Read More
Sun Pharma reports Q2 net profit at ₹3,040 Crore
29 Oct 2024|10:30 AM

Sun Pharma has bolstered its speciality pipeline with a partnership with Philogen to commercialise late-stage candidate Fibromun.

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.